Strip of 10 Units
Old MRP ₹223
MRP ₹209.06
₹167.25
₹20.91/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionDapanorm Duo 10 Tablet is used to treat type 2 diabetes mellitus in adults whose blood sugar is not adequately controlled. It combines dapagliflozin (SGLT2 inhibitor) and sitagliptin (DPP-4 inhibitor) to manage glucose levels. It is also useful for patients who cannot maintain control with either component alone or have contraindications to individual medicines. Take orally as directed. Notify your doctor if you have any side effects.
Dapanorm Duo 10 Tablet is used to treat blood sugar control in adults with type 2 diabetes. It is particularly useful for patients whose blood sugar is not adequately managed with dapagliflozin or sitagliptin alone, or when individual use of these medications is unsuitable due to intolerance or contraindications.
Here is how to take Dapanorm Duo-10 Tablet:
Swallow the tablet whole with a glass of water.
Do not crush, chew, or divide the tablet.
If you are unsure about any of these instructions, don't hesitate to consult your doctor.
Dapanorm Duo-10 Tablet is taken orally.
Dapanorm Duo 10 Tablet mau causes some side effects such as genital yeast infections, urinary tract infections, headache, nausea, and diarrhoea. Some people may also experience symptoms like a stuffy or runny nose or a mild sore throat while using this medicine.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Dapanorm Duo-10 Tablet. However, if you experience any serious side effects or worsening symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Diarrhoea: Try taking Dapanorm Duo-10 Tablet with food to lessen this effect.
Hypoglycaemia: If you feel dizzy or weak after taking this medicine, consider having your meals before you take it.
Dapanorm Duo-10 Tablet combines two active ingredients that work together to manage blood glucose levels:
Dapagliflozin (10 mg): This is a sodium-glucose co-transporter 2 (SGLT2) inhibitor, which works by blocking the reabsorption of glucose in your kidneys. This leads to increased excretion of glucose through your urine, thus reducing your blood sugar levels.
Sitagliptin (100 mg): This is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which increases the levels of certain hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones signal your pancreas to produce more insulin when blood sugar levels are high and reduce the amount of glucose produced by the liver.
These two different mechanisms work together to provide a synergistic effect in managing blood glucose levels in patients with type 2 diabetes mellitus.
Caution is advised while taking Dapanorm Duo-10 Tablet if you are pregnant. It is best to consult your doctor before taking this medicine.
The safety of Dapanorm Duo-10 Tablet during breastfeeding has not been established. Consult your doctor to understand the potential risks and benefits.
There is no known interaction between Dapanorm Duo-10 Tablet and alcohol. However, it's wise to limit alcohol consumption while managing diabetes, as it can affect blood sugar levels.
If you have liver problems, discuss them with your doctor before starting Dapanorm Duo-10 Tablet. This medicine may affect liver function.
Dapanorm Duo-10 Tablet is contraindicated in severe kidney impairment, end-stage renal disease, or if you are on dialysis. Discuss any kidney health issues with your doctor before using this medicine.
Dapanorm Duo-10 Tablet does not usually affect your ability to drive or operate machinery. However, some side effects like dizziness may affect some people's capacity to drive or use machines.
Dapanorm Duo-10 Tablet is contraindicated if you are allergic to dapagliflozin, sitagliptin, or any of the inactive ingredients in the tablet. Make sure to discuss this with your doctor before starting this medicine.
Caution is advised while giving Dapanorm Duo-10 Tablet to children under 18 years of age. Always consult your doctor before giving any medicine to a child.
Older patients should take Dapanorm Duo-10 Tablet under medical supervision as they may be more susceptible to its side effects. Caution is advised if patients are above 70 years of age. Your doctor will guide you based on your health status.
Dapanorm Duo-10 Tablet interacts with the following medicines:
Sulfonylurea Medications: Medicines like insulin may increase the risk of low blood sugar. Specific medications like insulin glargine or glimepiride can interact, leading to hypoglycaemia.
Diuretics: Medicines like furosemide or hydrochlorothiazide may increase the risk of dehydration and kidney problems when taken with Dapanorm Duo-10 Tablet.
NSAIDs: Medicines such as ibuprofen or naproxen can increase the risk of kidney problems when used with Dapanorm Duo-10 Tablet.
Dapanorm Duo-10 Tablet has no known interactions with specific foods.
Dapanorm Duo-10 Tablet interacts with the following diseases:
Type 1 Diabetes: Dapanorm Duo-10 Tablet is not indicated for use in patients with type 1 diabetes.
Kidney Disease: Patients suffering from severe kidney impairment, end-stage renal disease, or those on dialysis should avoid this medicine.
Liver Disease: If you have liver problems, this medicine could potentially exacerbate your condition.
Pancreatitis: A history of pancreatitis might increase the risk of developing pancreatitis while using the Dapanorm Duo-10 Tablet.
The daily dose of Dapanorm Duo-10 Tablet should be taken as advised by your doctor. The dosage will be tailored to your specific needs, considering factors such as the severity of your condition and how you respond to the medicine. It's imperative not to exceed the prescribed dosage without consulting your doctor.
In case an overdose occurs, symptoms may include intense nausea, vomiting, and low blood sugar levels. If these symptoms persist or worsen, it's essential to inform your doctor.
If you miss a dose of this medicine, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and continue with your regular dosing schedule. Do not increase your dosage without consulting your doctor.
Store Dapanorm Duo-10 Tablet at room temperature, ideally below 30°C.
Keep it in a tightly closed container to protect it from excess moisture.
Make sure the area is away from direct sunlight.
Always keep the medicine out of sight and reach of children.
Remember to use the tablet before the expiry date mentioned on the pack.
Regular exercise: Incorporating physical activity into your daily routine can help manage your blood sugar levels. This is beneficial for individuals taking Dapanorm Duo-10 Tablet for type 2 diabetes. Consult your doctor to tailor an exercise plan suitable for you.
Balanced diet: Consuming a balanced diet rich in fibre and low in refined sugars can help maintain healthy blood sugar levels. This is particularly crucial when managing type 2 diabetes with Dapanorm Duo-10 Tablet.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 Diabetes Mellitus |
| Drug Category | SGLT2 Inhibitor, DPP-4 Inhibitor |
| Therapeutic Category | Antidiabetic |
Dapanorm Duo-10 Tablet is used to manage type 2 diabetes in adults, along with diet and exercise.
It contains dapagliflozin and sitagliptin, which work together to decrease blood sugar levels by increasing insulin production and reducing glucose absorption.
No, if you're allergic to dapagliflozin, sitagliptin or any other ingredients in the tablet, you should avoid taking this medicine.
No, this medicine isn't recommended for patients with severe kidney problems, end-stage renal disease or those on dialysis.
Common side effects include genital yeast infections, urinary tract infections, headache, nausea, diarrhoea and a runny nose.
Yes, this medicine may interact with other medications. Always inform your doctor about all medicines you are taking.
Store them at room temperature (below 30°C), in a tightly closed container away from moisture and direct sunlight.
Check out Editorial Policy
MedlinePlus. (n.d.). Sitagliptin. Retrieved 1 April 2024, from https://medlineplus.gov/druginfo/meds/a614015.html
NHS. (n.d.). About Sitagliptin. Retrieved 1 April 2024, from https://www.nhs.uk/medicines/sitagliptin/about-sitagliptin/
U.S. Food and Drug Administration. (n.d.). FDA Label: Dapagliflozin. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/202293s026lbl.pdf
U.S. Food and Drug Administration. (n.d.). FDA Label: Sitagliptin. Retrieved 1 April 2024, from https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/021995s050lbl.pdf
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
29625 users bought this instead
Read More
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.10.1
2025 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
